SGAM
AMED

Smith Group Asset Management’s Amedisys AMED Stock Holding History

Smith Group Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,815
Closed -$6.08M – 371
2021
Q2 		$6.08M Buy
24,815
+24,800
+165,333% +$6.51M 0.3% 73
2021
Q1 		$4K Sell
15
-1,882
-99% -$531K ﹤0.01% 310
2020
Q4 		$556K Hold
1,897
– – 0.03% 126
2020
Q3 		$449K Sell
1,897
-730
-28% -$166K 0.02% 134
2020
Q2 		$522K Sell
2,627
-46
-2% -$8.58K 0.03% 128
2020
Q1 		$491K Sell
2,673
-100
-4% -$17.8K 0.03% 122
2019
Q4 		$463K Sell
2,773
-1,197
-30% -$178K 0.02% 152
2019
Q3 		$520K Sell
3,970
-10
-0.3% -$1.3K 0.02% 141
2019
Q2 		$483K Hold
3,980
– – 0.02% 154
2019
Q1 		$491K Sell
3,980
-13,230
-77% -$1.66M 0.02% 167
2018
Q4 		$2.02M Buy
+17,210
New +$2.03M 0.07% 127

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Smith Group Asset Management's AMED Position: Q3 2021 in Review

Smith Group Asset Management sold out of Amedisys (AMED) in Q3 2021, closing a stake of 24,815 shares — an estimated $6.08M sold.

Smith Group Asset Management first reported a position in AMED in Q4 2018 and held it in 11 quarters. The position peaked at $6.08M in Q2 2021. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Smith Group Asset Management reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Smith Group Asset Management sold 24,815 Amedisys shares in Q3 2021, an estimated $6.08M.
  • Smith Group Asset Management first reported a position in Amedisys in Q4 2018 and held it in 11 quarters.
  • Smith Group Asset Management's Amedisys position peaked at $6.08M in Q2 2021.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Smith Group Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.